Project Grant HT94252310278
Award Date 5/1/23
Completion Date 4/30/27
Dollars Obligated $2.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
- The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
- The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $723,456 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award supports research investigating the role of parkin-mediated mitophagy in susceptibility and resilience to mitochondrial toxicant exposures. This three-year research initiative will be conducted at UAB's Birmingham, Alabama...
- The University of Alabama at Birmingham (UAB) was awarded a $1,485,001 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on March 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "Overcoming Perturbations that Orchestrate Immune Exhaustion and Dysfunction in Breast Cancer,"...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $516,779 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025 through August 31, 2027. The research project, titled "Dystrophin in the Brain: Does Restoration of Circadian Rhythm Improve DMD Symptoms?" investigates the potential therapeutic effects of circadian rhythm restoration on Duchenne muscular...
- Federal Project Grant Summary The University of Alabama at Birmingham received a $1,317,584 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. This research initiative focuses on developing macrophage-centric prognostic biomarkers to improve outcomes for checkpoint blockade immunotherapy in melanoma treatment. The three-year project will advance biomedical research...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $650,845 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The award, which began July 1, 2025, and extends through June 30, 2028, supports advanced biomedical research aimed at identifying and validating diagnostic tools to improve...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $227,167 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2025, through June 30, 2028. The research project, titled "Macrophage-Centric Prognostic Biomarkers for Checkpoint Blockade Immunotherapy in Melanoma," focuses on developing and validating diagnostic biomarkers to improve patient...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $148,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded October 1, 2025, with a completion date of September 30, 2026. The award supports research investigating the polyol pathway's role in promoting renal cancer tumorigenesis through glucose-mediated lipogenesis mechanisms. The research will be conducted at UAB's Birmingham,...
- The University of Alabama at Birmingham (UAB) received a $724,115 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The purpose of this 3-year grant, awarded on September 1, 2024, is to conduct research on the utility of sodium nitrite in improving recovery after spinal cord injuries. As a leading research institution, UAB will leverage its expertise in biomedical engineering, neuroscience, and clinical trials to...